BCG波士顿咨询：2025年生物制药趋势报告（英文版）

Scientific understanding of the biological drivers of disease, combined with the ability to influence human biology, has never been greater. Looking ahead, we expect new development to accelerate, delivering a wave of breakthrough drugs that will transform the treatment of diseases in areas with significant unmet need. Momentum will be fueled by a surge in the identification of more compelling biological targets and the expansion of therapeutic modalities that enable modulation of both newly